Chemical ID
DAIDZEIN
Ubiquitous
No
| Dosage | Reference |
|---|---|
| LDlo=>5,000 mg/kg (orl mus) | Leung, A. Y. and Foster, S. 1995. Encyclopedia of Common Natural Ingredients 2nd Ed. John Wiley & Sons, New York. 649 pp. |
| LDlo=>800 mg/kg (ipr mus) | Leung, A. Y. and Foster, S. 1995. Encyclopedia of Common Natural Ingredients 2nd Ed. John Wiley & Sons, New York. 649 pp. |
Select a Results View:
Download these results as:
| Activity Sort descending | Dosage | Reference |
|---|---|---|
| Antialcoholic | not available | Duke, 1992 * |
| Antiarrhythmic | not available | Duke, 1992 * |
| Anticancer | not available | Duke, 1992 * |
| Anticephalagic | not available | Duke, 1992 * |
| Antidipsomanic | 150 mg/kg/day | Duke, 1992 * |
| Antiestrogenic | not available | Duke, 1992 * |
| Antihemolytic | not available | Duke, 1992 * |
| Antiinflammatory | not available | Duke, 1992 * |
| Antileukemic | IC50=>10 ug/ml | Life Sciences 55: 1061. |
| Antimelanomic | not available | Duke, 1992 * |
| Antimicrobial | not available | Duke, 1992 * |
| Antimutagenic | not available | Economic & Medicinal Plant Research, 6: 235. |
| Antiosteoporotic | not available | Duke, 1992 * |
| Antioxidant | 1/4 quercetin | Duke, 1992 * |
| Antiproliferative | not available | Duke, 1992 * |
| Antiradicular | 1/4 quercetin | Duke, 1992 * |
| Antispasmodic | not available | Duke, 1992 * |
| Antitumor-Promoter | not available | Duke, 1992 * |
| Antiviral | not available | Duke, 1992 * |
| Aromatase-Inhibitor | IC28=1 uM/l | Journal of Medicinal Food 2: 235.1999. |
Download these results as:
| Plant Name Sort descending | Plant Part | Low Parts Per Million | High Parts Per Million | Standard Deviation | Reference |
|---|---|---|---|---|---|
| Cicer arietinum | Sprout Seedling | not available | not available | not available | Duke, 1992 * |
| Cicer arietinum | Seed | not available | 0.0 | -0.6 | Kaufman,PB,Duke,JA,Brielmann,H,Boik,J and Hoyt,JE. 1997. A Comparative Survey of Leguminous Plants as Sources of the Isoflavones Genistein and Daidzein: Implications For Human Nutrition and Health. Journal of Alternative & Complementary Medicine 3(1):7-12 |
| Genista tinctoria | Shoot | not available | not available | not available | Duke, 1992 * |
| Glycine max | Cotyledon | 14.0 | 28.0 | not available | Duke, 1992 * |
| Glycine max | Plant | not available | not available | not available | Duke, 1992 * |
| Glycine max | Hypocotyl | 140.0 | 190.0 | not available | Duke, 1992 * |
| Glycine max | Shoot | not available | not available | not available | Duke, 1992 * |
| Glycine max | Seed | 8.0 | 328.0 | 1.4 | Duke, 1992 * |
| Glycine max | Root | not available | not available | not available | Duke, 1992 * |
| Glycine max | Testa | 7.0 | 10.0 | not available | Duke, 1992 * |
| Glycine max | Seed Coat | not available | not available | not available | Duke, 1992 * |
| Glycine max | Embryo | not available | not available | not available | Duke, 1992 * |
| Glycine max | Leaf | not available | not available | not available | Duke, 1992 * |
| Lens culinaris | Seed | not available | 5.2 | -0.5 | Kaufman,PB,Duke,JA,Brielmann,H,Boik,J and Hoyt,JE. 1997. A Comparative Survey of Leguminous Plants as Sources of the Isoflavones Genistein and Daidzein: Implications For Human Nutrition and Health. Journal of Alternative & Complementary Medicine 3(1):7-12 |
| Medicago sativa | Shoot | not available | not available | not available | Duke, 1992 * |
| Medicago sativa | Plant | not available | not available | not available | Duke, 1992 * |
| Phaseolus coccineus | Plant | not available | not available | not available | J.S. Glasby Dict.Pls Containing 2ndary Metabolite. 1991. |
| Phaseolus lunatus | Seed | 0.3 | 28.0 | -0.4 | Duke, 1992 * |
| Phaseolus vulgaris | Fruit | not available | not available | not available | Duke, 1992 * |
| Phaseolus vulgaris | Seed | 0.4 | 23.2 | -0.4 | Kaufman,PB,Duke,JA,Brielmann,H,Boik,J and Hoyt,JE. 1997. A Comparative Survey of Leguminous Plants as Sources of the Isoflavones Genistein and Daidzein: Implications For Human Nutrition and Health. Journal of Alternative & Complementary Medicine 3(1):7-12 |